The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo

Authors:

Abstract
No abstract available
Funding Information
  • NIHR Oxford Biomedical Research Centre
  • International Myeloma Foundation
  • Blood Cancer UK (15026)
  • National Institute for Health Research
  • Versus Arthritis

This publication has 53 references indexed in Scilit: